A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Clinical trial NCT07099391 · RECRUITING
Trial details
- NCT number
- NCT07099391
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-24
- Primary completion
- 2029-07-24
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.